Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion

Experimental and Molecular Pathology

Volumn 86, Issue 2, 2009, Pages 95-100

  Afify, Alaa ^a   Purnell, Phillip ^a   Nguyen, Laura ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Breast cancer; CD44; CD44v6 adhesion; Motility and invasion

Indexed keywords

CD44 ANTIBODY; CD44V6 ANTIGEN; HERMES ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN CELL; HYPOTHESIS; WESTERN BLOTTING;

ANTIGENS, CD44; BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; DRUG COMBINATIONS; FEMALE; HUMANS; HYALURONIC ACID; LAMININ; MOLECULAR WEIGHT; NEOPLASM INVASIVENESS; PROTEIN ISOFORMS; PROTEOGLYCANS;

EID: 62949171989     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.12.003     Document Type: Article

References (40)

1. Afify A., Craig S., Stern R., and Paulino A. Expression of hyaluronic acid and its receptors, CD44, CD44v6 in normal, hyperplastic and neoplastic endometrium. Ann. Diagn. Pathol. 9 (2005) 312-318
2. Afify A., McNiel A.M., Braggin J., and Bailey H. Expression of CD44s, CD44v6 and hyaluronan across the spectrum of normal-hyperplasia-carcinoma in breast. Appl. Immunohistochem. Mol. Morphol. 16 (2008) 121-128
3. American Cancer Society, INC, 2007. Breast Cancer Facts & Figures, Statistic.
4. Auvinen P., Tammi R., Tammi M., Johansson R., and Kosma V.M. Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan. Histopathology 47 (2005) 420-428
5. Bourguignon L. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J. Mammary Gland Biol. Neoplasia 6 (2001) 287-297
6. Bourguignon L. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin. Cancer Biol. 18 (2008) 251-259
7. Bourguignon L., Gunja-Smith Z., and Lida N. CD44v (3, 8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell. Physiol. 176 (1998) 206-215
8. Bourguignon L., Zhu H., Shao L., and Chen Y. Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and m igration. J. Cell Biol. 150 (2000) 177-191
9. Bourguignon L., Zhu H., Shao L., and Chen Y. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J. Biol. Chem. 276 (2001) 7327-7333
10. Brennan F.R., Mikecz K., Glant T.T., Jobanputra P., Pinder S., and Bavington C. CD44 expression by leucocytes in rheumatoid arthritis and modulation by specific antibody: implications for lymphocyte adhesion to endothelial cells and synoviocytes in vitro. Scand. J. Immunol. 45 (1997) 213-220
11. Camp R.L., Scheynius A., Johansson C., and Pure' E. CD44 is necessary for optimal contact allergic responses but is not required for normal leukocyte extravasation. J. Exp. Med. 178 (1993) 497-507
12. Carpenter P., and Dao A. The role of hyaluronan in mesothelium-induced motility of ovarian carcinoma cells. Anticancer Res. 23 (2003) 3985-3990
13. DeGrendele H.C., Estess P., Picker L.J., and Siegelman M.H. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 183 (1996) 1119-1130
14. Guo F., Gao Y., Wang L., and Zheng Y. p19Arf-p53 tumor suppressor pathway regulates cell motility by suppression of phosphoinositide 3-kinase and Rac1 GTPase activities. J. Biol. Chem. 278 (2003) 14414-14419
15. Herrera-Gayol A., and Jothy S. CD44 modulates Hs578T human breast cancer cell adhesion, migration, and invasiveness. Exp. Mol. Pathol. 66 (1999) 99-108
16. Joensuu H., Klemi P.J., Toikkanen S., and Jalkanen S. Glycoprotein CD44 expression and its association with survival in breast cancer. Am. J. PathoI. 143 (1993) 867-872
17. Lopez J., Camenisch T., and Stevens V.M. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res. 65 (2005) 6755-6763
18. Kimata K., Honma Y., Okayama M., Oguri K., and Hozumi M. Increased synthesis of hyaluronic acid by mouse mammary carcinoma cell variants with high metastatic potential. Cancer Res. 43 (1983) 1347-1354
19. Knudson W., Bartnik E., and Knudson C.B. Assembly of pericellular matrices by COS-7 cells transfected with CD44 lymphocyte-homing receptor genes. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 4003-4007
20. Kundson W., Aguiar D., Hua Q., and Kundson C. CD44- anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp. Cell Res. 228 (1996) 216-228
21. Lesley J., Hyman R., and Kincade P.W. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54 (1993) 271-335
22. Mikecz K., Brennan R., Kim H., and Glant T. Anti-CD44 treatment abrogates tissue edema and leukocyte infiltration in murine arthritis. Nat. Med. 1 (1995) 558-563
23. Naor D., Sionov R.V., and Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71 (1997) 241-319
24. Nemec R.E., Tool B.P., and Knudson W. The cell surface hyaluronate binding sites of invasive human bladder carcinoma cells. Biochem. Biophys. Res. Commun. 149 (1987) 249-257
25. Oertli B., Beck-Schimmer B., Fan X., and Wuthrich R.P. Mechanisms of hyaluronan-induced up-regulation of ICAM-1 and VCAM-1 expression by murine kidney tubular epithelial cells: hyaluronan triggers cell adhesion molecule expression through a mechanism involving activation of nuclear factor-kappa B and activating protein-1. J. Immunol. 161 (1998) 3431-3437
26. Oliferenko S., Kaverina I., Small J., and Huber L. Hyaluronic acid (HA) binding to CD44 activates Rac1 and induces lamellipodia outgrowth. J. Cell Biol. 148 (2000) 1159-1164
27. Park J., Kim S., and Park C. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Cancer Res. 62 (2002) 6318-6322
28. Peach R.J., Hollenbaugh D., Stamenkovic I., and Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. J. Cell Biol. 122 (1993) 257-264
29. Peterson R., Yu Q., Stamenkovic I., and Toole B. Perturbation of hyaluronan interactions by soluble CD44 inhibits growth of murine mammary carcinoma cells in ascites. Am. J. Pathol. 156 (2000) 2159-2167
30. Repesh L. A new in vitro assay for quantitating tumor cell invasion. Invasion Metastasis 9 (1989) 192-208
31. Suwiwat S., Ricciardelli C., Tammi R., Tammi M., and Auvinen P. Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer. Clin. Cancer Res. 10 (2004) 2491-2498
32. Tolg C., Hoffman M., and Herrlich P. Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acid Res. 21 (1993) 1225-1229
33. Toole B.P. Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 2 (1990) 839-844
34. Toole B.P. Hyaluronan promotes the malignant phenotype. Glycobiology 12 (2002) 37-42
35. Underhill C. CD44: the hyaluronan receptor. J. Cell. Sci. 103 (1992) 293-298
36. Wernicke M., Pineiro L.C., Caramutti D., Dorn V.G., and Raffo M.M. Breast cancer stromal myxoid changes are associated with tumor invasion and metastasis: a central role for hyaluronan. Mod. Pathol. 16 (2003) 99-107
37. Witty J., McDonnell S., Newell K., et al. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res. 54 (1994) 4805-4812
38. Yu Q., and Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13 (1999) 35-48
39. Zhong Z., Shigeki K., Qi H., Kenji O., Kensuke M., and Jayne L. Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J. Cell Biol. 130 (1995) 485-495
40. Zhu D., and Bourguignon L.Y. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell. Motil. Cytoskelet. 39 (1998) 209-222